Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000573085 | SCV000672433 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000765006 | SCV000896189 | uncertain significance | Acroleukopathy, symmetric; Pituitary dependent hypercortisolism; Somatotroph adenoma | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001202575 | SCV001373691 | uncertain significance | not provided | 2025-01-15 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 276 of the AIP protein (p.Ala276Val). This variant is present in population databases (rs61741147, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with AIP-related conditions. ClinVar contains an entry for this variant (Variation ID: 485056). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt AIP protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects AIP function (PMID: 27253664). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001202575 | SCV002571484 | uncertain significance | not provided | 2024-03-14 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Published functional studies demonstrate a damaging effect: increased rate of protein degradation compared to wildtype (PMID: 27253664); This variant is associated with the following publications: (PMID: 21512261, 27253664) |
Baylor Genetics | RCV003465251 | SCV004193517 | uncertain significance | Somatotroph adenoma | 2024-03-29 | criteria provided, single submitter | clinical testing |